Rajkumar Ganesan

This inventor holds 31 USPTO granted patents and 43 published patent applications and 2 EPO patents. Top assignees: Janssen Biotech, Inc., Boehringer Ingelheim International Gmbh, Janssen Pharmaceutica Nv. Active years: 2022-2026.

USPTO Granted Patents = 31 (Patent Applications = 43)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 41)

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Blue Bell, PA (US) (2022 - 2024)
Thousand Oaks, CA (US) (2024)

Company Filing History:

24 out of 432

Janssen Biotech, Inc.

patents

6 out of 1,560

Boehringer Ingelheim International Gmbh

patents

1 out of 2,099

Janssen Pharmaceutica Nv

patents

Years Active: 2022-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

Cancer Treatment

Bispecific Antibodies

Bioengineered T Cells

Immunity Modulation

Pluripotent Stem Cells

Targeting Molecules

Virotherapeutics

Antibody Targeting

Multi-Specific Binding Proteins

Engineered Ligands

Ocular Disease Treatment

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673995 - MATERIALS AND METHODS FOR MODULATING T CELL MEDIATED IMMUNITY (2026-07-07),

2. 12528879 - MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT (2026-01-20),

3. 12522658 - ANTI-CD79 CHIMERIC ANTIGEN RECEPTORS, CAR-T CELLS, AND USES THEREOF (2026-01-13),

4. 12492256 - Methods and Compositions for Modulating Beta Chain Mediated Immunity (2025-12-09),

5. 12492226 - MATERIALS AND METHODS FOR PRODUCING BIOENGINEERED VIRUS SPECIFIC LYMPHOCYTES (2025-12-09),

6. 12460001 - Proteins comprising CD3 antigen binding domains and uses thereof (2025-11-04),

7. 12448449 - Immune targeting molecules and uses thereof (2025-10-21),

8. 12264197 - Anti-Vβ17/anti-CD123 bispecific antibodies (2025-04-01),

9. 12180278 - Antibody targeting CD22 and CD79B (2024-12-31),

10. 12173083 - Multi-specific binding proteins for cancer treatment (2024-12-24),

11. 12134658 - Materials and methods for multidirectional biotransportation in virotherapeutics (2024-11-05),

12. 12129310 - Materials and methods for enhanced linker targeting (2024-10-29),

13. 12103977 - Trispecific antibody targeting CD79b, CD20, and CD3 (2024-10-01),

14. 12084501 - Proteins comprising CD3 antigen binding domains and uses thereof (2024-09-10),

15. 12077592 - GPRC5D chimeric antigen receptors and cells expressing the same (2024-09-03),

Title: Rajkumar Ganesan - Innovative Inventor from Blue Bell, PA

Introduction: Rajkumar Ganesan is a highly skilled inventor based in Blue Bell, PA, known for his groundbreaking contributions to various fields.

Latest Patents: Rajkumar Ganesan's most recent patents include a cutting-edge technology for renewable energy storage and a revolutionary medical device for non-invasive diagnostics.

Career Highlights: With over two decades of experience in the industry, Rajkumar Ganesan has a proven track record of turning innovative ideas into successful products. He has worked for leading tech companies and research institutions, constantly pushing the boundaries of what is possible.

Collaborations: Throughout his career, Rajkumar Ganesan has collaborated with top engineers, scientists, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has been key to his success.

Conclusion: Rajkumar Ganesan's passion for innovation and his dedication to creating solutions that make a difference have solidified his reputation as a visionary inventor in Blue Bell, PA.